难治性-话题@MedSci

#难治性#

683篇内容 | 2690人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1528502, encodeId=c2a215285021a, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=CHC2018丨刘蔚教授：难治性高血压药物治疗新认识, objectType=article, longId=146272, objectId=db291462e20b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db291462e20b, replyNumber=0, likeNumber=73, createdTime=2018-08-11, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db291462e20b, moduleTitle=CHC2018丨刘蔚教授：难治性高血压药物治疗新认识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db291462e20b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528501, encodeId=c4de15285019f, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=CHC2018丨吴海英教授：老年难治性高血压的诊疗策略, objectType=article, longId=146029, objectId=493514602941, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=493514602941, replyNumber=0, likeNumber=85, createdTime=2018-08-08, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=493514602941, moduleTitle=CHC2018丨吴海英教授：老年难治性高血压的诊疗策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=493514602941)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528500, encodeId=60bd1528500d1, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=lancet oncol：阿帕替尼联合依托泊苷用于铂类耐受性/难治性乳腺癌的效果和安全性, objectType=article, longId=145876, objectId=88e41458e6ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88e41458e6ed, replyNumber=0, likeNumber=113, createdTime=2018-08-06, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88e41458e6ed, moduleTitle=lancet oncol：阿帕替尼联合依托泊苷用于铂类耐受性/难治性乳腺癌的效果和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88e41458e6ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528499, encodeId=a5541528499fe, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Blood：来那度胺联合obinutuzumab用于复发性/难治性滤泡性B细胞淋巴瘤的安全性和疗效, objectType=article, longId=145755, objectId=8b22145e5508, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b22145e5508, replyNumber=0, likeNumber=56, createdTime=2018-08-05, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b22145e5508, moduleTitle=Blood：来那度胺联合obinutuzumab用于复发性/难治性滤泡性B细胞淋巴瘤的安全性和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b22145e5508)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528498, encodeId=587015284986d, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Blood：复发性或难治性结节性淋巴细胞为主型霍奇金淋巴瘤的更佳治疗方案, objectType=article, longId=145707, objectId=7eea145e07b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7eea145e07b9, replyNumber=0, likeNumber=51, createdTime=2018-08-04, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7eea145e07b9, moduleTitle=Blood：复发性或难治性结节性淋巴细胞为主型霍奇金淋巴瘤的更佳治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7eea145e07b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528497, encodeId=b97a152849e3c, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Medicine：诊断慢性难治性咳嗽的新见解, objectType=article, longId=145479, objectId=b1d31454e94c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1d31454e94c, replyNumber=0, likeNumber=46, createdTime=2018-07-31, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1d31454e94c, moduleTitle=Medicine：诊断慢性难治性咳嗽的新见解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1d31454e94c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528496, encodeId=fd8215284969d, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=JAMA Psychiatry：难治性抑郁症的成本效果：电惊厥疗法vs药物治疗/心理疗法, objectType=article, longId=145312, objectId=39ee1453124c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39ee1453124c, replyNumber=0, likeNumber=58, createdTime=2018-07-29, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39ee1453124c, moduleTitle=JAMA Psychiatry：难治性抑郁症的成本效果：电惊厥疗法vs药物治疗/心理疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39ee1453124c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528495, encodeId=295b152849561, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Cancer Sci：人类去势难治性前列腺中卡巴他赛抗性机制分析, objectType=article, longId=145186, objectId=a73b14518629, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a73b14518629, replyNumber=0, likeNumber=59, createdTime=2018-07-27, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a73b14518629, moduleTitle=Cancer Sci：人类去势难治性前列腺中卡巴他赛抗性机制分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a73b14518629)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528494, encodeId=fdf01528494ff, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=FDA批准**IDH1抑制剂用于治疗复发或难治性AML, objectType=article, longId=145063, objectId=68c9145063ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68c9145063ea, replyNumber=0, likeNumber=77, createdTime=2018-07-25, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68c9145063ea, moduleTitle=FDA批准**IDH1抑制剂用于治疗复发或难治性AML, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68c9145063ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528493, encodeId=dda8152849305, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Brit J Cancer：雄激素受体剪接变异AR-V3, AR-V7和AR-V9在去势难治性前列腺癌转移中是持续共表达的, objectType=article, longId=144947, objectId=441414494efb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=441414494efb, replyNumber=0, likeNumber=72, createdTime=2018-07-24, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=441414494efb, moduleTitle=Brit J Cancer：雄激素受体剪接变异AR-V3, AR-V7和AR-V9在去势难治性前列腺癌转移中是持续共表达的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=441414494efb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528492, encodeId=8d741528492fb, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Haematologica：鲁索利替尼治疗晚期复发/难治性霍奇金淋巴瘤效果如何？, objectType=article, longId=144692, objectId=895114469266, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=895114469266, replyNumber=0, likeNumber=69, createdTime=2018-07-20, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=895114469266, moduleTitle=Haematologica：鲁索利替尼治疗晚期复发/难治性霍奇金淋巴瘤效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=895114469266)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528491, encodeId=850615284914d, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Am J Respir Crit Care Med：XEN-D0501并不能减小难治性咳嗽患者的咳嗽频率, objectType=article, longId=144651, objectId=a94814465196, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a94814465196, replyNumber=0, likeNumber=55, createdTime=2018-07-19, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a94814465196, moduleTitle=Am J Respir Crit Care Med：XEN-D0501并不能减小难治性咳嗽患者的咳嗽频率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a94814465196)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528490, encodeId=adda15284904a, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Int J Clin Pharmacol Ther：新型钠通道阻滞剂GSK2339345治疗难治性慢性咳嗽的疗效, objectType=article, longId=144649, objectId=6b3e144649d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b3e144649d6, replyNumber=0, likeNumber=74, createdTime=2018-07-19, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b3e144649d6, moduleTitle=Int J Clin Pharmacol Ther：新型钠通道阻滞剂GSK2339345治疗难治性慢性咳嗽的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b3e144649d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528489, encodeId=bf2d15284891a, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Brit J Haematol：复发或复发性难治性MM，伊布鲁蒂尼单用或联合地塞米松结果喜人, objectType=article, longId=144542, objectId=f8ec1445427a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8ec1445427a, replyNumber=0, likeNumber=58, createdTime=2018-07-18, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8ec1445427a, moduleTitle=Brit J Haematol：复发或复发性难治性MM，伊布鲁蒂尼单用或联合地塞米松结果喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8ec1445427a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528488, encodeId=bea6152848887, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Ann Rheum Dis：类风湿性关节炎中的bDMARD难治性疾病, objectType=article, longId=142768, objectId=b0bf142e6880, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0bf142e6880, replyNumber=0, likeNumber=62, createdTime=2018-07-10, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0bf142e6880, moduleTitle=Ann Rheum Dis：类风湿性关节炎中的bDMARD难治性疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0bf142e6880)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528487, encodeId=638c152848e56, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Janssen的esketamine在治疗难治性抑郁症中的第三阶段成功, objectType=article, longId=141134, objectId=88a6141134f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88a6141134f2, replyNumber=0, likeNumber=87, createdTime=2018-06-21, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88a6141134f2, moduleTitle=Janssen的esketamine在治疗难治性抑郁症中的第三阶段成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88a6141134f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528486, encodeId=6c981528486bc, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Am J Otolaryngol：难治性高频突发性耳聋挽救治疗中的两种疗法比较, objectType=article, longId=141117, objectId=100714111e56, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=100714111e56, replyNumber=0, likeNumber=76, createdTime=2018-06-21, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=100714111e56, moduleTitle=Am J Otolaryngol：难治性高频突发性耳聋挽救治疗中的两种疗法比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=100714111e56)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528485, encodeId=bc9815284857f, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=JCO：Pembrolizumab用于难治性或复发性胸腺上皮肿瘤患者：开放性II期试验, objectType=article, longId=140934, objectId=089b1409347d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=089b1409347d, replyNumber=0, likeNumber=27, createdTime=2018-06-18, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=089b1409347d, moduleTitle=JCO：Pembrolizumab用于难治性或复发性胸腺上皮肿瘤患者：开放性II期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=089b1409347d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528484, encodeId=36691528484d7, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Prostate Cancer P D：在转移去势难治性前列腺癌男性中，RECIST响应能够成功的预测阶段3试验么？, objectType=article, longId=140909, objectId=a804140909e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a804140909e6, replyNumber=0, likeNumber=81, createdTime=2018-06-17, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a804140909e6, moduleTitle=Prostate Cancer P D：在转移去势难治性前列腺癌男性中，RECIST响应能够成功的预测阶段3试验么？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a804140909e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528483, encodeId=0de81528483ee, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Lancet：Upadacitinib，选择性JAK1抑制剂，可快速改善难治性类风湿关节炎患者症状, objectType=article, longId=140780, objectId=68e0140e800a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68e0140e800a, replyNumber=0, likeNumber=22, createdTime=2018-06-16, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68e0140e800a, moduleTitle=Lancet：Upadacitinib，选择性JAK1抑制剂，可快速改善难治性类风湿关节炎患者症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68e0140e800a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

难治性

2020-05-29

freve (审核中...)

前往app查看评论内容

#难治性#

CHC2018丨刘蔚教授：难治性高血压药物治疗新认识

2018-08-11

freve (审核中...)

前往app查看评论内容

#难治性#

CHC2018丨吴海英教授：老年难治性高血压的诊疗策略

2018-08-08

freve (审核中...)

前往app查看评论内容

#难治性#

lancet oncol：阿帕替尼联合依托泊苷用于铂类耐受性/难治性乳腺癌的效果和安全性

2018-08-06

freve (审核中...)

前往app查看评论内容

#难治性#

Blood：来那度胺联合obinutuzumab用于复发性/难治性滤泡性B细胞淋巴瘤的安全性和疗效

2018-08-05

freve (审核中...)

前往app查看评论内容

#难治性#

Blood：复发性或难治性结节性淋巴细胞为主型霍奇金淋巴瘤的更佳治疗方案

2018-08-04

freve (审核中...)

前往app查看评论内容

#难治性#

Medicine：诊断慢性难治性咳嗽的新见解

2018-07-31

freve (审核中...)

前往app查看评论内容

#难治性#

JAMA Psychiatry：难治性抑郁症的成本效果：电惊厥疗法vs药物治疗/心理疗法

2018-07-29

freve (审核中...)

前往app查看评论内容

#难治性#

Cancer Sci：人类去势难治性前列腺中卡巴他赛抗性机制分析

2018-07-27

freve (审核中...)

前往app查看评论内容

#难治性#

FDA批准**IDH1抑制剂用于治疗复发或难治性AML

2018-07-25

freve (审核中...)

前往app查看评论内容

#难治性#

Brit J Cancer：雄激素受体剪接变异AR-V3, AR-V7和AR-V9在去势难治性前列腺癌转移中是持续共表达的

2018-07-24

freve (审核中...)

前往app查看评论内容

#难治性#

Haematologica：鲁索利替尼治疗晚期复发/难治性霍奇金淋巴瘤效果如何？

2018-07-20

freve (审核中...)

前往app查看评论内容

#难治性#

Am J Respir Crit Care Med：XEN-D0501并不能减小难治性咳嗽患者的咳嗽频率

2018-07-19

freve (审核中...)

前往app查看评论内容

#难治性#

Int J Clin Pharmacol Ther：新型钠通道阻滞剂GSK2339345治疗难治性慢性咳嗽的疗效

2018-07-19

freve (审核中...)

前往app查看评论内容

#难治性#

Brit J Haematol：复发或复发性难治性MM，伊布鲁蒂尼单用或联合地塞米松结果喜人

2018-07-18

freve (审核中...)

前往app查看评论内容

#难治性#

Ann Rheum Dis：类风湿性关节炎中的bDMARD难治性疾病

2018-07-10

freve (审核中...)

前往app查看评论内容

#难治性#

Janssen的esketamine在治疗难治性抑郁症中的第三阶段成功

2018-06-21

freve (审核中...)

前往app查看评论内容

#难治性#

Am J Otolaryngol：难治性高频突发性耳聋挽救治疗中的两种疗法比较

2018-06-21

freve (审核中...)

前往app查看评论内容

#难治性#

JCO：Pembrolizumab用于难治性或复发性胸腺上皮肿瘤患者：开放性II期试验

2018-06-18

freve (审核中...)

前往app查看评论内容

#难治性#

Prostate Cancer P D：在转移去势难治性前列腺癌男性中，RECIST响应能够成功的预测阶段3试验么？

2018-06-17

freve (审核中...)

前往app查看评论内容

#难治性#

Lancet：Upadacitinib，选择性JAK1抑制剂，可快速改善难治性类风湿关节炎患者症状

2018-06-16

科室
- - 订阅+
  - 更多科室
工具
服务